Ani Pharmaceuticals Inc
ANIP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001023024
In the last 90 days, Ani Pharmaceuticals Inc insiders filed 0 open-market purchases and 11 sales; 307 institutions reported holding it in 13F filings for Q2 2026, worth $1.90B in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Ani Pharmaceuticals Inc as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 285
- +18 vs. Q3 2025
- Shares held
- 21.2M
- +810.5K (+4.0%) vs. Q3 2025
- Total value
- $1.67B
- −$193.4M (−10.4%) vs. Q3 2025
- New holders
- 49
- 114 more added
- Sold out
- 31
- 77 more reduced
2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANIP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 307 | $1.90B |
| Q1 2026 | 281 | $1.80B |
| Q4 2025 | 285 | $1.67B |
| Q3 2025 | 269 | $1.87B |
| Q2 2025 | 233 | $1.29B |
| Q1 2025 | 231 | $1.34B |
| Q4 2024 | 206 | $1.07B |
| Q3 2024 | 208 | $1.12B |
| Q2 2024 | 201 | $962.3M |
| Q1 2024 | 200 | $975.2M |
| Q4 2023 | 181 | $750.8M |
| Q3 2023 | 186 | $766.4M |
| Q2 2023 | 172 | $662.5M |
| Q1 2023 | 138 | $411.7M |
| Q4 2022 | 126 | $412.4M |
| Q3 2022 | 126 | $330.3M |
| Q2 2022 | 120 | $293.4M |
| Q1 2022 | 126 | $258.8M |
| Q4 2021 | 132 | $413.4M |
| Q3 2021 | 118 | $238.8M |
| Q2 2021 | 116 | $252.7M |
| Q1 2021 | 106 | $263.5M |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Ani Pharmaceuticals Inc; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighTower Advisors, LLC | 0 | $0 | 0.00% | −4,969−100.0% | Sold out |
| Quadrature Capital Ltd | 0 | $0 | 0.00% | −4,320−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −3,911−100.0% | Sold out |
| STRS Ohio | 0 | $0 | 0.00% | −3,600−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −3,027−100.0% | Sold out |
| Scientech Research LLC | 0 | $0 | 0.00% | −2,803−100.0% | Sold out |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −2,692−100.0% | Sold out |
| Change Path, LLC | 0 | $0 | 0.00% | −2,418−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −2,213−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −388−100.0% | Sold out |
| Optiver Holding B.V. | 0 | $0 | 0.00% | −120−100.0% | Sold out |
| GPS Wealth Strategies Group, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| Mather Group, LLC. | 0 | $0 | 0.00% | −31−100.0% | Sold out |
| Principal Securities, Inc. | 0 | $0 | 0.00% | −16−100.0% | Sold out |
| Atlantic Trust, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Tortoise Investment Management, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | – | – | – | – | Not filed |
| Point72 (DIFC) Ltd | – | – | – | – | Not filed |